Literature DB >> 2815075

Clinical study of drug fever induced by parenteral administration of antibiotics.

K Oizumi1, K Onuma, A Watanabe, M Motomiya.   

Abstract

The incidence and clinical features of drug fever induced by antibiotics were investigated. Of a total of 390 patients analyzed, 193 had malignant diseases (lung cancer in most cases) and the remaining 197 had non-malignant diseases, of which the majority comprised pulmonary infectious diseases such as pneumonia, lung abscess and chronic infections. beta-Lactams most frequently induced drug fever. Piperacillin induced drug fever in 18 of 108 (17%), cefotaxime in 11 of 72 (15%), ceftizoxime in 7 of 49 (14%) and cefoperazone in 6 of 74 patients (8%). In contrast, the incidence of drug fever caused by ampicillin and that by cefazolin were in one of 39 (3%) and in none of 44 (0%), respectively. On the other hand, antimicrobial agents other than beta-lactams only rarely induced drug fever. The higher incidence of drug fever caused by newer derivatives of beta-lactam antibiotic suggests that the side chain attached to their core moiety might be involved in the mechanism of drug fever. In patients with malignancy who were on antibiotics, respiratory infection was the most frequent cause of fever exceeding 38 degrees C. In contrast, in patients with non-malignant diseases, the use of antibiotic per se was the most frequent cause of the fever which recurred during antibiotic therapy after a previous febrile episode had subsided. The most common feature of drug fever induced by the use of an antibiotic was as follows: A low-grade fever at the time of onset is followed by a high and remittent fever. The highest diurnal body temperature rises gradually, and then the fever subsides promptly after cessation of the causative antibiotic. The fever of this type accounted for 70% of all the drug fever in this study. A transient elevation of serum level of lactic dehydrogenase was associated with drug fever in one half (25/49, 51%) of the patients. A transient and slight decrease from the normal range in counts of neutrophils and platelets were observed in 11 (23%) and in 4 (8%) of 48 patients with drug fever, respectively. These changes in laboratory findings were considered as the possible consequence of allergic processes involved in the development of drug fever and thus seem to be a helpful index for establishing the diagnosis of drug fever.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2815075     DOI: 10.1620/tjem.159.45

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  7 in total

Review 1.  Fever after maxillofacial surgery: a critical review.

Authors:  Amelia Christabel; Ravi Sharma; R Manikandhan; P Anantanarayanan; N Elavazhagan; Pramod Subash
Journal:  J Maxillofac Oral Surg       Date:  2014-01-14

2.  Drug Fever: a descriptive cohort study from the French national pharmacovigilance database.

Authors:  Dominique Vodovar; Christine LeBeller; Bruno Mégarbane; Agnes Lillo-Le-Louet; Thomas Hanslik
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

3.  Antibiotic-induced fever in orthopaedic patients-a diagnostic challenge.

Authors:  Kirsten Labbus; Jana Karina Junkmann; Carsten Perka; Andrej Trampuz; Nora Renz
Journal:  Int Orthop       Date:  2018-03-29       Impact factor: 3.075

4.  When antibiotics appear to fail.

Authors:  G R Monif
Journal:  Infect Dis Obstet Gynecol       Date:  1997

5.  An Unusual Cause of Fever in a Patient with Total Hip Replacement.

Authors:  Raju Vaishya; Amit Kumar Agarwal; Vipul Vijay
Journal:  Cureus       Date:  2016-02-14

6.  Rifampicin-Induced Fever in a Patient with Brucellosis: A Case Report.

Authors:  Mesut Yilmaz; Canan Yasar; Selda Aydin; Okan Derin; Bahadir Ceylan; Ali Mert
Journal:  Drug Saf Case Rep       Date:  2018-02-09

7.  Acute subdural haemorrhage in the postpartum period as a rare manifestation of possible HELLP (haemolysis, elevated liver enzymes, and low-platelet count) syndrome: a case report.

Authors:  Malitha Patabendige
Journal:  BMC Res Notes       Date:  2014-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.